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Abstract: Mammalian cells are constantly subjected to a variety of DNA damaging events that
lead to the activation of DNA repair pathways. Understanding the molecular mechanisms of the
DNA damage response allows the development of therapeutics which target elements of these
pathways. Double-strand breaks (DSB) are particularly deleterious to cell viability and genome
stability. Typically, DSB repair is studied using DNA damaging agents such as ionising irradiation
or genotoxic drugs. These induce random lesions at non-predictive genome sites, where damage
dosage is difficult to control. Such interventions are unsuitable for studying how different DNA
damage recognition and repair pathways are invoked at specific DSB sites in relation to the local
chromatin state. The RNA-guided Cas9 (CRISPR-associated protein 9) endonuclease enzyme is a
powerful tool to mediate targeted genome alterations. Cas9-based genomic intervention is attained
through DSB formation in the genomic area of interest. Here, we have harnessed the power to
induce DSBs at defined quantities and locations across the human genome, using custom-designed
promiscuous guide RNAs, based on in silico predictions. This was achieved using electroporation of
recombinant Cas9-guide complex, which provides a generic, low-cost and rapid methodology for
inducing controlled DNA damage in cell culture models.
Keywords: DNA damage; Cas9; double-strand break; DNA repair
1. Introduction
One of the most critical processes for living organisms is to maintain genome integrity
using DNA damage surveillance and repair mechanisms. These mechanisms prevent cells
from progressing through cell division, which would propagate the defective genome to
daughter cells [1]. If lesions are not repaired, mutations can accumulate, leading to cell
senescence, ageing and the onset of disease, such as cancer.
Approximately 10–50 double-strand breaks (DSBs) occur per cell cycle in human
cells [2,3]. DSBs are considered one of the most genotoxic types of DNA damage because
both DNA strands are severed, and thus any error in correctly re-joining the broken ends
may lead to insertions, translocations, deletions and chromosome fusions that further
promote genome instability [4]. Multiple competing repair programmes exist in order
to repair such lesions, including error-free (homologous recombination (HR)) and error-
prone (non-homologous end joining (NHEJ), mismatch-mediated end joining (MMEJ))
pathways [4]. The choice of which repair pathway is invoked depends on the nature of
the break, on the local chromatin context and on cell cycle stage. When the nature or level
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of DNA damage is beyond repair, apoptotic mechanisms are activated [5]. This apoptotic
response is frequently exploited by cytotoxic drugs such as bleomycin or cisplatin, which
induce severe aberrations within the DNA structure. Understanding the mechanisms
involved in pathway choice for DSB repair is crucial to develop targeted therapeutic
interventions in cancer cells, as, for example, is the case of poly-ADP ribose polymerase
(PARP) inhibitors in Brca1-deficient cancers [6].
In order to study DSB response mechanisms, damage must first be induced. To date,
this has largely been achieved using untargeted genotoxic drugs and/or irradiation. While
this allows some definition of how DSB repair varies according to cell type, it does not
allow interrogation of how repair is influenced by local chromatin states, which can alter
upon damage [7]. More targeted approaches have also been developed for the study of
DSBs, reliant upon the inducible expression of restriction endonucleases that sever the
DNA helix at specific locations. These experimental systems encompass the use of Ppol [8],
SceI [9] and AsiSI enzymes [10]—each of which cuts the DNA in different locations, and
which may be introduced to cells either transiently, or via genomic incorporation of an
inducible transgene. In particular, inducible expression of AsiSI using the DSB Inducible
via AsiSI (DiVA) cell line has been instrumental in beginning to unpick the complexity of
DNA repair pathway choice in different genomic contexts [10].
However, each of these systems only addresses a very limited selection of chromosome
regions due to the requirement for specific restriction enzyme cut sites. SceI is a mega-
nuclease with no endogenous recognition site in mammalian genomes, and thus its target
sequence must be transgenically introduced into the desired location in the genome. Ppol has
several recognition sites within ribosomal RNA repeats and thus only allows the study of the
nucleolar DNA damage response. AsiSI is methylation-sensitive and cuts at non-methylated
CpG-rich sequences, which are primarily located at promoters and enhancers [10]. There is
an urgent need within the field to expand the toolbox to allow wider interrogation of DNA
responses in different chromatin contexts, and—equally importantly—different cell types.
Therefore, we wished to design a methodology to induce a tuneable number of DSBs
in a broad range of genomic contexts. This can be used to probe the context specificity
of DNA damage responses and pathway choice. Programmable endonucleases such as
Transcription activator-like effector nucleases (TALENS) or Zinc finger nucleases (ZFNs),
and CRISPR-Cas9, have all been widely used to allow DSB induction at arbitrary genomic
loci. However, typically, these programmed approaches are designed to generate a single
DSB at a single specific site for the purpose of gene targeting, with broader induction of
DNA damage seen as a disadvantage [11–15]. Here, in contrast, we use electroporation
of recombinant Cas9 and synthetic promiscuous guide RNAs to introduce multiple DSBs
in mammalian cell culture, with both the number of breaks and the desired target context
being tuneable (Figure 1A). This will allow us to assess the DNA damage response across
a wide range of damage severity, at specified genomic locations, in any electroporatable
cell type.
2. Materials and Methods
2.1. Constructs
Plasmid pET-Cas9-NLS-6xHis responsible for encoding SpCas9 (wild-type Cas9 de-
rived from S. pyogenes) containing nuclear localisation signal (NLS) sequence and 6x-
Histidine tag fused at the C-terminal, was obtained from Addgene (#62933). Plasmid
pET302-6His-dCas9-Halo, the equivalent nuclease-deficient Cas9, was obtained from Ad-
dgene (#72269). All plasmids were verified by DNA sequencing.
2.2. Protein Expression and Purification in Escherichia coli
Recombinant constructs were expressed in E.coli BL21 DE3 cells (Invitrogen) in Luria
Bertani media. Proteins were purified by affinity chromatography (HisTrap FF, GE Health-
care, Chicago, IL, USA). The purest fractions were then further purified through a Superdex
200 16/600 column (GE Healthcare, Chicago, IL, USA).
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2.3. Cell Culture
MCF10a (ATCC CRL-10317) cells were cultured at 37 ◦C and 5% CO2, in 50% Gibco
Minimal Essential Media (MEM) Alpha medium with GlutaMAX (no nucleosides) and
50% Ham’s F-12 nutrient mixture, supplemented with 5% Foetal Bovine Serum (Gibco),
5% horse serum, penicillin-streptomycin mix diluted to 100 units mL−1, 50 µg Cholera
toxin, 5 µg insulin, 20 ngmL−1 human EGF and 0.5 µgmL−1 hydrocortisone, 100 units/mL
penicillin and 100 µg/mL streptomycin (Gibco).
2.4. Drug Treatment
Cisplatin [cis-diammineplatinum(II) dichloride] (Sigma) was resuspended in a 0.9%
NaCl solution to a concentration of 3.3 mM, following manufacturer’s instructions, and
used at a concentration of 25 µM.
2.5. Electroporation
MCF10A cells were harvested with 0.25% trypsin/EDTA centrifugation at 500 rpm,
4 ◦C. The cells were then resuspended in 37 ◦C Opti-MEM Reduced Serum Medium
(Gibco).
Both crRNA (Dharmacon) and tracrRNA (Dharmacon Edit-R CRISPR-Cas9 Synthetic
tracrRNA-U-002005-20) stock solutions (200 µM each) were prepared by adding the ap-
propriate volume of RNase-free water. Then, the 100 µM solution of crRNA:tracrRNA
duplex was created by combining 200 µM stock solutions in a 1:1 ratio. The solution was
gently mixed for 10 min and stored at −20 ◦C for future experiments. The project also
utilised HS17 crRNA (5′-CAGACAGGCCCAGATTGAGG-3′) from Berg et al. [16]. The
Cas9 ribonucleoprotein (RNP) complex was created by combining 1.5 µM Cas9 protein and
3 µM RNA final concentration and kept on ice until being mixed with the resuspended
cells in Opti-MEM medium.
Electroporation of the Cas9:RNA complex was achieved using Gene Pulser/MicroPulser
Electroporation Cuvettes with 0.2 cm gap cuvettes at in the Gene Pulser Xcell Electropora-
tion System and an exponential pulse at 300 V and 300 µF. Complete cell culture media was
then added to the Opti-MEM in a 1:1 ratio. Electroporated MCF10A cells were seeded on
to coverslips pre-coated with 50 µg/mL poly-D-lysine (Sigma, St. Louis, MO, USA) and
incubated at 37 ◦C in 5% CO2.
2.6. Immunofluorescence
MCF10a cells were fixed for 15 min at room temperature in 4% (w/v) paraformalde-
hyde (PFA) in Tris-buffered Saline (TBS) and residual PFA was quenched for 15 min with
50 mM ammonium chloride in TBS. For staining with Halo-Tetramethyl Rhodamine (TMR)
(Promega G8252), 10 nM ligand was added for 15 min and washed three times in warm
cell culture media before fixation. All subsequent steps were performed at room temper-
ature. Cells were permeabilised and simultaneously blocked for 15 min with 0.1% (v/v)
Triton X-100 and 2% (w/v) bovine serum albumin (BSA) in TBS. Cells were then immuno-
stained by 1 h incubation with the indicated primary and subsequently the appropriate
fluorophore-conjugated secondary antibody (details below), both diluted in 2% (w/v) BSA
in TBS. The following antibodies were used at the indicated dilutions: Rabbit anti-Cas9
(1:200, Abcam ab204448), Mouse anti-phospho-H2A.X (1:500 Sigma, St. Louis, MO, USA
05-636), Donkey anti-rabbit Alexa Fluor 488-conjugated (1:250, Abcam, Cambridge, UK
Ab181346) and Donkey anti-mouse Alexa Fluor 647-conjugated (1:250, Abcam, Cambridge,
UK Ab150103). For Hoechst staining, coverslips were washed three times in TBS followed
by Hoechst 33342 solution for 10 min at room temperature (RT) in the dark. The coverslips
were then washed three times in TBS and once with ddH2O. Coverslips were mounted
on microscope slides with Mowiol (10% (w/v) Mowiol 4-88, 25% (w/v) glycerol, 0.2 M
Tris-HCl, pH 8.5), supplemented with 2.5% (w/v) of the anti-fading reagent DABCO (Sigma,
St. Louis, MO, USA).
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2.7. Widefield Fluorescent Imaging
Widefield immunofluorescence images were obtained using a CytoVision Olympus
BX61 microscope equipped with an Olympus UPlanFL 100 X/1.30 NA oil objective lens
and a Hamamatsu Photonics Digital CCD Camera ORCA-R2 C10600-10B-H.
2.8. Confocal Imaging
Cells were visualised using the ZEISS LSM 880 confocal microscope. This was
equipped with a Plan-Apochromat 63×/1.4 NA oil immersion lens (Carl Zeiss, Jena,
Germany 420782-9900-000). The built-in dichroic mirrors (Carl Zeiss, Jena, Germany
MBS-405, MBS-488 and MBS-561) were used to reflect the excitation laser beams onto cell
samples. The emission spectral bands for fluorescence collection were 410–524 nm (Hoechst,
Thermo Fisher, Waltham, MA, USA), 493–578 nm (AlexaFluor 488, Thermo Fisher, Waltham,
MA, USA) and 650–697 nm (AlexaFluor 647, Thermo Fisher). The detectors consisted of
two multi-anode photomultiplier tubes (MA-PMT) and one gallium arsenide phosphide
(GaAsP) detector. The green channel was imaged using a GaAsP detector, while the blue
and red channels were imaged using MA-PMTs. ZEN software (Carl Zeiss, Jena, Germany
ZEN 2.3) was used to acquire and render the confocal images.
2.9. Image Analysis
For single particle detection, we used Fiji [17] to split the RGB channels and convert
the γH2AX channel to a binary image. The Despeckle function was used to remove
background noise from the images. The area of the nucleus was selected by creating a mask
from the Hoechst channel. The Analyse Particles function was used to calculate the number
of foci in a given nucleus. For fluorescence intensity measurements, the binary image for
single particle detection was used to create a mask and then the mean pixel intensity was
calculated for each particle.
2.10. STochastic Optical Reconstruction Microscopy (STORM) Imaging
Cells were seeded on pre-cleaned No. 1.5, 25 mm round glass coverslips, placed
in 6-well cell culture dishes. Glass coverslips were cleaned by incubating them for 3 h,
in etch solution, made of 5:1:1 ratio of H2O:H2O2 (50 wt.% in H2O, stabilized, Fisher
Scientific, Waltham, MA, USA): NH4OH (ACS reagent, 28–30% NH3 basis, Sigma), placed
in a 70 ◦C water bath. Cleaned coverslips were repeatedly washed in filtered water
and then ethanol, dried, and used for cell seeding. Cells were fixed in pre-warmed 4%
(w/v) Paraformaldehyde (PFA) in Phosphate-Buffered Saline (PBS) and residual PFA
was quenched for 15 min with 50 mM ammonium chloride in PBS. Immunofluorescence
was performed in filtered sterilised TBS. Cells were permeabilized and simultaneously
blocked for 30 min with 3% (w/v) BSA in TBS, supplemented with 0.1% (v/v) Triton X-100.
Permeabilized cells were incubated for 1 h with the primary antibody and subsequently
the appropriate fluorophore-conjugated secondary antibody, at the desired dilution in 3%
(w/v) BSA, 0.1% (v/v) Triton X-100 in TBS. The antibody dilutions used were the same
as for the normal immunofluorescence (IF) protocol (see above), except for the secondary
antibodies which were used at 1:250 dilution. Following incubation with both primary and
secondary antibodies, cells were washed 3 times, for 10 min per wash, with 0.2% (w/v) BSA,
0.05% (v/v) Triton X-100 in TBS. Cells were further washed in PBS and fixed for a second
time with pre-warmed 4% (w/v) PFA in PBS for 10 min. Cells were washed in PBS and
stored at 4 ◦C, in the dark, in 0.02% NaN3 in PBS, before proceeding to STORM imaging.
Before imaging, coverslips were assembled into the Attofluor® cell chambers (In-
vitrogen, Carlsbad, CA, USA). Imaging was performed in freshly made STORM buffer
consisting of 10% (w/v) glucose, 10 mM NaCl, 50 mM Tris, pH 8.0, supplemented with
0.1% (v/v) 2-mercaptoethanol and 0.1% (v/v) pre-made GLOX solution, which was stored
at 4 ◦C for up to a week (5.6 % (w/v) glucose oxidase and 3.4 mg/mL catalase in 50 mM
NaCl, 10 mM Tris, pH 8.0). All chemicals were purchased from Sigma.
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Imaging was undertaken using the Zeiss Elyra PS.1 system. Illumination was from a
HR Diode 642 nm (100 mW) laser, where power density on the sample was 7–12 kW/cm2.
Imaging was performed under highly inclined and laminated optical (HILO) illumina-
tion to reduce the background fluorescence with a 100×/1.46 NA oil immersion objective
lens (Zeiss alpha Plan-Apochromat) with a BP 420–480/BP495–550/LP 650 filter. The final
image was projected on an Andor iXon EMCCD camera with 25 ms exposure for 20,000
frames. The focal plane was locked using the Definite Focus function in the microscope
during image acquisition.
The images were processed through our STORM analysis pipeline using the Zeiss
Zen Black software. Single molecule detection and localisation was performed using a
9-pixel mask with a signal-to-noise ratio of 6 in the “Peak finder” settings while applying
the “Account for overlap” function. This function allows multi-object fitting to localise
molecules within a dense environment. Molecules were then localised by fitting to a
2D Gaussian.
The render was then subjected to model-based cross-correlation lateral drift correction
and detection grouping to remove detections within multiple frames. Typical localisa-
tion precision was 20 nm for Alexa-Fluor 647. The final render was then generated at
10 nm/pixel and displayed in Gauss mode, where each localisation is presented as a 2D
Gaussian with a standard deviation (SD) based on its precision. The localisation table was
exported as a csv for import into Clus-DoC.
2.11. Clus-DoC
The single molecule positions were exported from Zeiss Zen Black and imported into
the Clus-DoC analysis software [18] (https://github.com/PRNicovich/ClusDoC accessed
on 14 September 2020). The region of interest was determined by the nuclear staining. First,
the Ripley K function was completed to identify the r max. The r max was then assigned
for DBSCAN. The MinPts was 3 and a cluster required 10 locations, with smoothing set
at 7 nm and epsilon set at the mean localisation precision for the dye. All other analyses
parameters remained at default settings [18]. Data concerning each cluster was exported
and graphed using Plots of Data [19].
2.12. In Silico Design of Guide RNAs
The crRNAs used in this project were designed using FlashFry developed by McKenna
and Shendure [20]. FlashFry was downloaded from Github—https://github.com/mckennalab/
FlashFry (accessed on 14 September 2020)—and configured according to the authors’ recom-
mendations. The binary database was created based on the latest human genome (hg38 build)
in FASTA format from UCSC. The verification of the newly designed crRNA hits across the
human genome was done in BLAST/BLAT search from Ensembl with adjusted option to
report the maximum number of hits to report to 5000, E-value for alignment report at 1.0,
match/mismatch scores equal to 1 and −1, with filtering low-complexity regions and query
sequences options enabled.
3. Results
3.1. Proof-of-Concept Using Electroporation of Recombinant Cas9
Our approach utilises electroporation of recombinant Cas9 instead of traditional
transfection or engineering stable expression within cell line models. This reduces the
perturbation to the cell line, removes the time delay to express Cas9 and enables mul-
tiple cells lines to be readily studied. We first established the electroporation efficiency
with nuclease-deficient Cas9 (dCas) to avoid any complications arising from non-specific
nuclease activity. We electroporated Halo-dCas9 into MCF10a cells and then stained the
cells with TMR halo-ligand. On average, we observed that 40% of cells contained dCas9
(Figure 1B). To demonstrate the versatility of this approach, we also electroporated HeLa
cells (Supplementary Figure S1), and on average, achieved 60% transfection.
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Figure 1. Electroporation of Cas9 to induce DNA damage. (A) Cartoon depicting the methodol-
ogy. Recombinant Cas9 is bound to the crRNA and tracrRNA (i). The complex is then electro-
porated into the mammalian cell line (ii). DNA damage is then detected and quantified using fluo-
rescent markers (iii). (B) Example of a widefield image of Halo-dCas9 in MCF10a cells stained 
with TMR ligand (magenta) and Hoechst for DNA (blue). Scale bar is 10 µm. (C) 
Figure 1. Electroporation of Cas9 to induce DNA damage. (A) Cartoon depicting the methodology.
Recombinant Cas9 is bound to the crRNA and tracrRNA (i). The complex is then electroporated
into the mammalian cell line (ii). DNA damage is then detected and quantified using fluorescent
markers (iii). (B) Example of a widefield image of Halo-dCas9 in MCF10a cells stained with TMR
ligand (magenta) and Hoechst for DNA (blue). Scale bar is 10 µm. (C) Immunofluorescence staining
against Cas9 (green) and γH2AX (red) in MCF10a cells. Electroporation is a control for background
signals. Cas9 refers to electroporation of only Cas9. HS17 is the guide RNA predicted to cut the
genome at 17 locations. DNA was stained with Hoechst (blue). Scale bar is 10 µm. (D,E) Quantitative
image analysis from the experiments in (C). The Number of Foci per nucleus and Mean Foci Intensity
per nucleus are plotted for each condition. Each data point is an individual nucleus. The p-value
is calculated from a two-tailed t-test. (F) Immunofluorescence staining of γH2AX in MCF10a cells
following treatment with 25 µM cisplatin for 4 h.
We then assessed the ability of wild-type Cas9-RNA complex to be electroporated
and induce DNA damage. For this, we used a previously designed promiscuous crRNA
guide to induce up to 17 DSBs (HS17) [16]. The Cas9-RNA complex was pre-formed and
then electroporated into MCF10a cells. Immunofluorescence staining against Cas9 marked
electroporated cells and γH2AX staining was used as a read-out of DNA damage. The
latter was quantified in terms of number of foci and total nuclear intensity. Electroporation
without guide RNA did not induce DNA damage. However, DNA damage was induced
through electroporation of the Cas9-RNA complex (Figure 1C–E), as occurred following
exposure of the cells to cisplatin (Figure 1F). Overall, we conclude that this approach is
viable for inducing DNA damage, independent of cell line engineering.
3.2. Design of Promiscuous Guide RNAs
Having shown that the electroporation method is feasible, we et out to design a
series of pro iscuous guide RNAs to in uce DNA damage across a rang of sites. The
FlashFry software [20] compresses the genome into an orga ised index for easier and
faster discovery of target sequences. This was used to identify 23 bp (crRNA/protospacer
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adjacent motif + sequence) target sites in the human genome. A total of five sequences
were selected from the generated output list (Table 1).
Table 1. Candidate sequences for promiscuous targeting of the human genome. Predicted number of
hits are presented from FlashFry and Ensembl.
Name crRNA Sequence (5′-3′) FlashFry Hits Ensembl Hits
50A ACCCCTGGCAGCTGCGGTTCAGG 54 53
50B TATAATAAGCAAATTGCAATGGG 52 50
100A GGGGCTTCCAGGTCACAGGTAGG 111 100
100B ACTTTAAGTTTTAGGGTACATGG 100 100
150 GTGCCAGAAATCTGGCCACCAGG 158 154
Sequences were selected based on the prediction that each would cut at 50, 100 and 150
locations within the human genome, with a PAM sequence matching nGG or nGA. There
is consensus between the predicted cuts using FlashFry and Ensembl (Table 1). Specifically,
there are two versions for each of the 50 and 100 crRNA sequences. These target relatively
GC-rich sequences 50A (60.9% GC) and 100A (56.5% GC), or AT-rich regions 50B (69.6%
AT) and 100B (60.9% AT). A quantified overview of the hits per chromosome is summarised
in Supplementary Figure S2, including hits relative to the number of bases for a given
chromosome. The hits are randomly distributed across the chromosomes but not all
chromosomes are targeted with each guide. In addition to these, we used the previously
designed HS17 gRNA (see above).
3.3. Tuning the Number of DNA Damage Sites Using Cas9 and Promiscuous Guides
Single Particle Analysis of DNA Damage Foci
As in the proof-of-concept experiment, the formation of γH2AX foci was used as a
marker of DNA damage to report upon the activity of Cas9 in complex with the guide
RNAs following electroporation. Electroporation alone, or with only Cas9, showed minimal
γH2AX staining and foci formation (Figure 2).
Upon electroporation of the Cas9:RNA complex, formation of γH2AX foci can be ob-
served from one hour following electroporation (Figure 2) through the six hour observation
window. These results confirm that the promiscuous guides are viable for the induction of
DSBs through Cas9 nuclease activity.
To investigate the induction of DSBs quantitatively, we used single particle image
analysis on widefield images of nuclei. Consistent with Figure 2, the majority of the
cells in the control measurements revealed minimal DNA damage for all time courses
(mean foci cell−1 = 1.3). Electroporation of the Cas9:RNA complexes led to a significant
accumulation of γH2AX foci for all guide RNA, except centromere, compared to controls
(Figures 1D and 2).
Despite the presence of foci 1 h post-electroporation, the number of foci detected varies
across the time course between the different guide RNAs. For example, the mean number
of foci with 100B electroporated cells remains constant at approximately 15.5 foci cell−1
throughout the time course, while in 100A electroporated cells, the number of foci increased
up to 2 h and then decreased in the following 4 h. However, all of the conditions are capable
of retaining a large number of γH2AX foci within the 6 h timeframe because either DNA
damage repair is incomplete or Cas9 remains active. In Supplementary Figure S3, we can
confirm that the electroporated Cas9 is still present within the population of cells. The
temporal difference is potentially due to variations in cut and repair efficiencies within the
different genomic regions.
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Figure 2. Time course of Cas9-induced DNA damage. Example widefield images of MCF10a cells
stained for DNA with Hoechst (blue) and γH2AX (red). Electroporation is a control for background
signals. Cas9 refers to electroporation of Cas9 alone. HS17 is the crRNA predicted to cut the genome
at 17 locations [16], while 50A/B, 100A/B and 150 are our designed promiscuous crRNA which cut
at 50, 100 and 150 predicted sites, respectively. ‘A’ versions are GC-selective sequences while ‘B’
versions are AT-selective. The timing is measured from electroporation onwards. Scale bar is 10 µm.
Using guide RNAs with increasing predictive cuts led to a broader distribution in the
number of γH2AX foci (Figure 3). However, the overall cell response to the cuts shows
that only a small population of electroporated cells are capable of reaching the predicted
number of cuts, such as those electroporated with HS17 (30%) and few (7%) in the case of
50A and 50B (Figure 3). This may relate to the accessibility of the sites to nuclease activity.
Occasionally, there are cells like in HS17, 50A and 50B that display twice the number of
predicted cuts, suggesting that these are cells in G2/M phase with duplicated genomes.
The are no trends across the time courses between AT or GC sequence bias. For example,
there are differences between 50A and 50B at 4 h, and AT-selective 50B guide generates
more foci. Whereas, the GC-selective 100A has more foci at 2 h.
Caution must be exercised when attempting to count absolute values when a high
density of foci needs to be measured in a spatially and genomically confined region, and
through the use of widefield imaging in a single focal plane.
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well-resolved and clearly visible throughout the nuclear body (Figure 4B,D). Particle anal-
ysis was then performed across the 3D stack and as expected, we resolved more foci for 
each guide (Figure 4E). Specifically, we observed a mean of 49 and 35 foci cell−1 for 50A 
and 50B respectively, compared to 17 and 16 foci cell−1 observed in conventional widefield 
microscopy. Thus, when resolved by confocal stacking, the average foci count is signifi-
cantly closer to the expected number of cuts. In the confocal analysis, our ability to detect 
a high number of particles is not a limiting factor, as shown by applying the same confocal 
Figure 3. Quantification of DNA damage foci. Quantitative image analysis, as described in the
Methods Section, from the experiments in Figure 2. Foci were determined based on staining of
γH2AX. The number of foci per nucleus is plotted for each crRNA (Table 1). Each data point is an
in ividual n cleus. The p-value is calculated from a two-tailed t-test and the error bars represent
st n ard deviation (SD). Th mean values are pres nted.
To address these technical limitations and to provide further validation of our ap-
proach, we performed confocal microscopy to extract a three-dimensional (3D) volume
to better quantify the number of foci. This enabled us to correctly quantify particles that
overlap in 2D but are separated in 3D, although the overall spatial resolution remains
similar to widefield imaging. We used the 50A and 50B guides at the 2 h measurements
(Figure 4A–D). This time point was chosen because it was possible to resolve statistically
significant differences between the predicted 17, 50 and 100 cuts. The γH2AX foci were
well-resolved and clearly visible throughout the nuclear body (Figure 4B,D). Particle anal-
ysis was then performed across the 3D stack and as expected, we resolved more foci for
each guide (Figure 4E). Specifically, we observed a mean of 49 and 35 foci cell−1 for 50A
and 50B respectively, compared to 17 and 16 foci cell−1 observed in conventional wide-
field microscopy. Thus, when resolved by confocal stacking, the average foci count is
significantly closer to the expected number of cuts. In the confocal analysis, our ability to
detect a high number of particles is not a limiting factor, as shown by applying the same
confocal approach with cells treated with cisplatin (Figure 4F), where we detect an average
of 136 foci.
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Figure 4. Impact of imaging methods upon the quantification of γH2AX foci. (A,B) Confocal image
and nuclear z-stack at 500 nm intervals of MCF10a cells stained for DNA with Hoechst (blue) and
γH2AX (red), 2 h after electroporation with Cas9 and 50A guide (GC-selective). Scale bar: 10 µm.
(C,D) The equivalent measurement with AT-selective 50B guide. Scale bar: 10 µm. (E) Quantitative
image analysis to determine the number of foci per nucleus. ‘WF’ refers to standard widefield
imaging, as shown in Figure 2. ‘Con’ denotes confocal imaging, as shown in (A–D). ‘STORM’ refers
to the number of f ci determined by super r solution imaging and cluster analysis in panels (F,G).
A comparison is shown for MCF10a cells treated with 25 µM cisplatin for 4 h. Each data point is
an individual nucleus. The p-value is calculated from a two-tailed t-test comparing measurements
to the standard widefield imaging and the error bars represent SD. The mean values are presented.
(F) Confocal image of γH2AX in MCF10a cells following treatment with 25 µM cisplatin for 4 h.
Scale bar: 10 µm. (G) Example STORM render image of γH2AX, 2 h after electroporation with Cas9
and 50A guide (GC-selective) (scale bar 2 µm). (H) Cluster map from panel (F) depicting density of
γH2AX molecules per µm2. Clusters are defined by detecting a minimum of 3 molecules within a
search area corresponding to the STORM localisation precision. The search area then propagates and
a group of molecules is considered to be a cluster if at least 10 molecules are found.
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The confocal analysis reinforces the ability of our method to induce a quantitatively
variable level of DNA damage, depending on the chosen guide sequence. To further ad-
dress this point, we performed single molecule localisation microscopy (STORM) analysis
with the 50A guide 2 h measurement (Figure 4G). This approach is equivalent to the wide-
field imaging performed in Figures 2 and 3, but with approximately five-fold increased
resolution and the ability to count single molecules and quantify clusters [21,22]. We
detected γH2AX foci and then quantified the foci using cluster analysis (Figure 4H). Dense
clusters were identified, as expected for γH2AX foci following DNA damage. We observed
an average of 37 clusters cell−1, again significantly higher than standard widefield imaging
and close to the predicted number of cut sites (Figure 4E).
Overall, the above results show that widefield imaging leads to merging of nearby cut
sites and thus underestimation of the true number of foci. However, when comparing the
number of foci detected in widefield imaging across all the different guides tested, we can
observe a good linear correlation between the predicted cut number and the mean detected
foci at all time points up to 2 h (Figure 5). This is with the exception of 100B, which did
not vary across the time course. This correlation is critical to the dosage response given
by using Cas9. Overall, as previously found in DiVA cells [10], the 2 h time point appears
optimal for obtaining the desired levels of DNA damage, representing the best trade-off
between the kinetics of damage induction and repair.
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3.4. Tuning the Amount of NA Damage Using Cas9 and Promiscuous Guides
Intensity-Based Quantification of DNA Damage
Particle analysis has optical limitations relating to the detection of individual foci. As
a second independent approach to damage quantitation, we investigated the mean γH2AX
fluorescence intensity across nuclei for each of the selected guide RNAs. This removes the
need for resolving individual DSBs and instead provides an overall aggregate measure of
the level of DNA damage and γH2AX signal.
As expected, mean intensity (Figure 6A) was significantly higher than the control
measurements for all guide RNAs tested (Figure 1E). Moreover, there was once again a
temporal increase in mean intensity, suggesting that damage accumulates up to 4 h and
begins to decrease, depending on the guide. Interestingly, the centromere guide can be
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distinguished from the HS17 guide at 2 h and it appears that the damage is largely repaired
by 6 h. This is consistent with a resolution limitation when performing the single particle
analysis based on foci counting. Consistent with the prior data, using guide RNAs with
increasing predicted cuts led to an increase in total γH2AX staining intensity. However,
exploring the data more closely shows that the 150 guide is an outlier because the intensity
cannot be distinguished from the other guides. Moreover, the 100B guide responded
differently to 100A across the time course. This may suggest that the nuclease activity is not
efficient with these guides, and therefore it is important to validate the use of the guides in
this manner before performing experiments.
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(A) Quantitative image analysis, as described in the Methods Section, from the experiments shown
in Figure 2. The mean intensity per nucleus is plotted for each guide RNA. Each data point is an
individual nucleus. The p-value is calculated from a two-tailed t-test and the error bars represent SD.
The mean values are presented. The time refers to hours post-electroporation. (B) Linear correlation
plots of mean intensity per nuclei following electroporation with guide RNA to induce 17, 50, 100
and 150 cuts. The bars represent the 95% CI. The data for 150 did not vary across the time course so it
was removed from the correlation fitting.
The number of foci subsided quickly after the 2 h measurements, yet the intensity
measurements do not follow this trend. It is therefore possible that foci are fusing for repair,
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thus reducing the overall number of foci but maintaining overall γH2AX levels. This once
again highlights the need for caution when only applying particle analysis.
There was a correlation between expected cuts and mean intensity for up to 100 cuts, as
with the particle detection (Figure 6B). This reinforces the lack of effective cutting with the
150 guide because the intensity was lower than expected in all time points. Nevertheless, the
positive correlation, up to 100 cuts, was observed across all time points, which highlights
the gain of using intensity over particle detection methods. It also implies there are foci
fusion events occurring as repair occurs during the latter time points.
4. Discussion
We have described that by using a programmable Cas9 system, it is possible to induce
and detect targeted and titratable DNA damage (DSBs) and quantitate this via γH2AX
immunostaining. This approach is an expansion upon the work of van der Berg et al. [16]
in an attempt to establish a functional proof-of-concept for designing crRNAs that have
multiple recognition sites for DSB-induction at lower logistical cost.
The electroporation of large ribo-protein complexes such as Cas9-guide RNA has high
versatility and can be applied to almost any cell line without any prior cell line engineering.
Importantly, electroporation does not cause measurable damage resulting in false positives.
We implemented two image analysis-based approaches to determine the efficiency
of damage induction. As expected, due to the additive nature of the fluorescence signal,
intensity measurements were more robust to determine differences between the guide
RNAs. Particle detection, with the aim of directly counting damage sites, was dependent
upon the resolution of the microscopy technique employed. Our data showed that the
γH2AX response is linear up to 100 cuts but it is likely that not all potential sites are cut
by Cas9. Overall, it is not possible to predict the precise number of cuts based on in silico
design alone, and it is therefore important that the guides are validated, as performed here,
before use. By using a cocktail of several crRNAs with fewer cuts each, similarly to Zhou
et al., it might be possible to specify even precisely the number of cuts induced in any given
experiment [23]. However, this comes with a trade-off in that increasing the number of
different guides used will decrease the concentration of any given guide delivered to each
cell. This may reduce cutting efficiency, as well as increasing the individual cell variability
depending on the precise amounts of the different guides taken up by each cell. Moreover,
the variation in cutting efficiency at the various potential sites for each gRNA is itself
informative about the accessibility of the chromatin to damage and subsequent repair and
will be amenable to study using recently developed tools such as BLESS and qDSB-Seq,
that measure the relative frequencies of DSBs at known locations [24,25].
We acknowledge that engineered cell lines which stably express Cas9 and the guides
will have a greater damage induction efficiency within a cell population. However, gen-
erating engineered cell lines at scale is not practical, and thus this approach cannot be
used for, e.g., high-throughput comparison of DNA damage responses across different
cell types. In contrast, our approach allows targeted DNA damage induction in any elec-
troporatable cell line. This dovetails well with recently developed techniques such as
CUT&Run and CUT&Tag [26,27], that are optimised for analysis of chromatin marks from
small numbers of cells. Coupling these techniques with a low-cost method of targeting
multiple DSBs to known locations—as presented here—will allow systematic exploration
of double-strand break repair for a range of tissues and cell types. Ultimately, we envisage
an “atlas” showing which DNA repair pathways are invoked in each different genomic
context, and each cell type, and how this varies dependent on the number of breaks per
cell. Further modifications are possible, for example the use of Cas9 nickase to compare
the response to single- versus double-strand breaks or coupling nuclease-dead Cas9 to a
fluorescent sensitiser to systematically explore the response to targeted oxidative damage.
Overall, therefore, our approach of using promiscuous guide RNAs represents an
important new means to target DNA damage to a range of desired genomic regions in an
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inducible and titratable manner. This will add to the repertoire of techniques available to
dissect the sophisticated DNA damage response across cell types and chromatin contexts.
Supplementary Materials: The following are available online at https://www.mdpi.com/2218-273
X/11/2/288/s1, Figure S1: Electroporation of HeLa cells, Figure S2: Overview of genomic targeting
for the crRNA, Figure S3: Time course of Cas9 in MCF10a cells following electroporation.
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